In PC, Shan et al. (2020) demonstrated through a series of studies that the promotion of chemoresistance in PC is mediated by CAF-derived sEVs carrying miR-423-5p, which targets GREM2. This evidence concerns the gene GREM2 and pachyonychia congenita.